← Leaderboards
Shan Lu
University Of Cincinnati
$1,325,359
Attributed
$1,325,359
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $266.8K · FY2007–11$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,325,359 · 1
By mechanism
R01$1,325,359 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Joan M Cook-Mills$17,204,943
- Stephen M Strakowski$19,964,072
- David Y Hui$27,378,958
- Melissa P. Delbello$14,466,785
- Guochang Fan$11,837,069
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateAblationHormonesHormone Refractory Prostate CancerAndrogen ReceptorBaseAndrogensAndrogen Independent Prostate CancerCancer ModelAnimal ModelAttenuatedCessation Of LifeClinical ResearchDetectionDh DomainCancer CellCancer EtiologyEpitheliumExtracellularGleason Grade For Prostate CancerCell GrowthGrowthGuanine Nucleotide Exchange FactorsMediating
Grant awards (5)
Vav3 Oncogene in Prostate Cancer$258,757
R01 · FY2011 · CA · contact PI
Vav3 Oncogene in Prostate Cancer$266,760
R01 · FY2010 · CA · contact PI
Vav3 Oncogene in Prostate Cancer$266,760
R01 · FY2009 · CA · contact PI
Vav3 Oncogene in Prostate Cancer$266,760
R01 · FY2008 · CA · contact PI
Vav3 Oncogene in Prostate Cancer$266,322
R01 · FY2007 · CA · contact PI